Maximus, Inc. (NYSE:MMS – Get Free Report) CFO David Mutryn acquired 1,000 shares of the stock in a transaction that occurred on Monday, February 9th. The stock was purchased at an average cost of $75.62 per share, with a total value of $75,620.00. Following the completion of the acquisition, the chief financial officer owned 40,037 shares of the company’s stock, valued at $3,027,597.94. The trade was a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Maximus Trading Up 5.5%
NYSE:MMS opened at $79.22 on Wednesday. The company has a market cap of $4.32 billion, a PE ratio of 12.06 and a beta of 0.56. The business’s 50 day moving average is $89.69 and its two-hundred day moving average is $86.63. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same period in the prior year, the company posted $1.61 EPS. The business’s revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Increases Dividend
Hedge Funds Weigh In On Maximus
A number of institutional investors and hedge funds have recently added to or reduced their stakes in MMS. Norges Bank bought a new position in Maximus during the fourth quarter valued at about $60,393,000. Goldman Sachs Group Inc. lifted its holdings in Maximus by 218.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock valued at $50,379,000 after acquiring an additional 400,315 shares during the last quarter. Boston Partners boosted its position in shares of Maximus by 113.6% during the 2nd quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock valued at $46,435,000 after purchasing an additional 349,529 shares in the last quarter. UBS Group AG grew its stake in shares of Maximus by 76.8% in the 4th quarter. UBS Group AG now owns 610,354 shares of the health services provider’s stock worth $52,686,000 after purchasing an additional 265,095 shares during the last quarter. Finally, River Road Asset Management LLC bought a new stake in shares of Maximus in the 2nd quarter worth approximately $18,073,000. 97.21% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on MMS. Weiss Ratings reissued a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Saturday. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, Maximus currently has an average rating of “Strong Buy”.
Check Out Our Latest Research Report on MMS
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Further Reading
- Five stocks we like better than Maximus
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
